eZono AG, a Jena, Germany-based developer of portable tablet ultrasound systems, has raised $10m in funding.
The round was led by MVM Life Science Partners.
The company intends to use the capital to expand its research and development operations in Jena and invest in global sales operations.
In conjunction with the funding, MVM partner Hugo Harrod will join eZono’s board.
Founded in July 2004 and led by Allan R. Dunbar, CEO, the company develops and markets tablet style ultrasound systems for emerging markets like regional anaesthesia and emergency care. Its first generation eZono 3000 system achieved CE mark in May 2009 and FDA 510k in July 2011. The eZono 3000 is now sold in more than 30 countries globally.